Publications by authors named "Israel Bendit"

Claim this Profile
A
Assessing the genetic profile of cytochrome P450 and glutathione S-transferases of patients diagnosed with acute myeloid leukemia.
Gilmar de Andrade França, Luciana Nardinelli, Ricardo Rodrigues Giorgi, Thiago Pagliarini, Otávio César Carvalho Guimarães Baiocchi, Israel Bendit

Hematol Transfus Cell Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel variants of the ATRX gene identified in MYCN non-amplified Neuroblastoma in Brazilian patients.
Thamiris Magalhães Gimenez, Vanessa Pretes Peralta, Ricardo Rodrigues Giorgi, Karina Morikawa, Carolina Camargo Vince, Israel Bendit

Clinics (Sao Paulo)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological inhibition of ezrin reduces proliferative and invasive phenotype in acute lymphoblastic leukemia cells.
Jean Carlos Lipreri da Silva, Keli Lima, Benjamin Ede, Mariana Lazarini, Hugo Passos Vicari, Israel Bendit

Eur J Pharmacol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of Philadelphia-like-related genes in a resource-constrained setting of adult B-acute lymphoblastic leukemia patients.
Keli Lima, César Alexander Ortiz Rojas, Frederico Lisboa Nogueira, Wellington Fernandes da Silva, Rita de Cássia Cavaglieri, Israel Bendit

EJHaem· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia.
Keli Lima, Frederico Lisboa Nogueira, Marcella Cipelli, Maria Fernanda Lopes Carvalho, Diego Antonio Pereira-Martins, Israel Bendit

Eur J Pharmacol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic implications of ΔNp73/TAp73 expression ratio in core-binding factor acute myeloid leukemia.
Maria L Salustiano-Bandeira, Amanda Moreira-Aguiar, Diego A Pereira-Martins, Juan L Coelho-Silva, Isabel Weinhäuser, Israel Bendit

Blood Cancer J· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Imatinib Mesylate Treatment in Patients with Chronic Myeloid Leukemia: The Importance of Molecular Monitoring and the Early Molecular Response.
Amanda Pifano Soares Ferreira, Fernanda Salles Seguro, Andre Ramires Neder Abdo, Fernanda Maria Santos, Felipe Vieira Rodrigues Maciel, Israel Bendit

Ann Hematol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Real‑world imatinib mesylate treatment in patients with chronic myeloid leukemia: The importance of molecular monitoring and the early molecular response.
Amanda Pifano Soares Ferreira, Fernanda Salles Seguro, Andre Ramires Neder Abdo, Fernanda Maria Santos, Felipe Vieira Rodrigues Maciel, Israel Bendit

Ann Hematol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult acute lymphoblastic leukemia in a resource-constrained setting: outcomes after expansion of genetic evaluation.
Wellington F Silva, Mariane T Amano, Luiza L Perruso, Maria Gabriella Cordeiro, Renata Kiyomi Kishimoto, Israel Bendit

Hematology· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients.
Luís Alberto de Pádua Covas Lage, Guilherme Carneiro Barreto, Hebert Fabricio Culler, Jéssica Billar Cavalcante, Lucas Bassolli de Oliveira Alves, Israel Bendit

Cancer Biomark· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brazilian chronic myeloid leukemia working group recommendations for discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia in clinical practice.
Carla Boquimpani, Fernanda Salles Seguro, Gustavo Henrique Romani Magalhães, Ingrid Luise Soares Pinto, Israel Bendit

Hematol Transfus Cell Ther· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of pregnancy on the outcomes of childbearing age women with chronic myeloid leukemia.
Fernanda Maria Santos, Giovanna Ghelfond, Fernanda Salles Seguro, Andre Neder R Abdo, Thales Dalessandro, Israel Bendit

Am J Hematol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 in chronic myeloid leukemia patients in Latin America.
Katia B Pagnano, Evelyn Herrera Peralta, Juan Ramon Navarro, Lourdes Del Rosario David Salas, Nancy Delgado, Israel Bendit

Leuk Lymphoma· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in Chronic Myeloid Leukemia Management in South America.
Katia B Pagnano, Ana Ines Varela, Carolina Pavlovsky, Israel Bendit, Vaneuza A M Funke

Curr Hematol Malig Rep· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis.
Hagop M Kantarjian, Timothy P Hughes, Richard A Larson, Dong-Wook Kim, Surapol Issaragrisil, Israel Bendit

Leukemia· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis.
Hagop M Kantarjian, Timothy P Hughes, Richard A Larson, Dong-Wook Kim, Surapol Issaragrisil, Israel Bendit

Leukemia· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MR 4log and low levels of NK cells are associated with higher molecular relapse after imatinib discontinuation: Results of a prospective trial.
Fernanda S Seguro, Felipe V R Maciel, Fernanda M Santos, André N R Abdo, Thales D M Pereira, Israel Bendit

Leuk Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter comparative acute myeloid leukemia study: can we explain the differences in the outcomes in resource-constrained settings?
Douglas R A Silveira, Juan L Coelho-Silva, Wellington F Silva, Grant Vallance, Diego A Pereira-Martins, Israel Bendit

Leuk Lymphoma· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular-Based Score inspired on metabolic signature improves prognostic stratification for myelodysplastic syndrome.
Juan L Coelho-Silva, Douglas R A Silveira, Diego A Pereira-Martins, Cesar A O Rojas, Antonio R Lucena-Araujo, Israel Bendit

Sci Rep· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MEG3 and MEG8 aberrant methylation in an infant with neuroblastoma.
Estela M Novak, Thamiris M Gimenez, Nathalia H Neves, Carolina C Vince, Ana Cristina V Krepischi, Israel Bendit

Pediatr Blood Cancer· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage treatment for refractory or relapsed acute myeloid leukemia: a 10-year single-center experience.
Wellington Fernandes da Silva, Lidiane Inês da Rosa, Fernanda Salles Seguro, Douglas Rafaele Almeida Silveira, Israel Bendit

Clinics (Sao Paulo)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of somatic TP53 mutations and 17p deletions in patients with chronic lymphocytic leukemia: a review of the current methods.
Maria de Lourdes L F Chauffaille, Ilana Zalcberg, Wolney Gois Barreto, Israel Bendit

Hematol Transfus Cell Ther· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating clinical features with genetic factors enhances survival prediction for adults with acute myeloid leukemia.
Douglas R A Silveira, Lynn Quek, Itamar S Santos, Anna Corby, Juan L Coelho-Silva, Israel Bendit

Blood Adv· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inclusion of molecular monitoring (BCR-ABL1) in the treatment of chronic myeloid leukemia in the Brazilian Public Health System (SUS): an urgent need for treatment management.
Carla Maria Boquimpani, André Neder Ramires Abdo, Denise Pires Martins, Luciana Britto de Abreu Lima, Mayde Seadi Torriani, Israel Bendit

Hematol Transfus Cell Ther· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-occurrence of DNMT3A, NPM1, FLT3 mutations identifies a subset of acute myeloid leukemia with adverse prognosis.
Matheus F Bezerra, Aleide S Lima, Maria-Riera Piqué-Borràs, Douglas R Silveira, Juan L Coelho-Silva, Israel Bendit

Blood· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis